Alnylam Pharmaceuticals, Inc. (0HD2.L)
Alnylam Pharmaceuticals, Inc.
$202.64+0.00%
StockGlow Score
Bullish
BearishBullish
1 year ago-48.9%
The outlook
Alnylam Pharmaceuticals, Inc. currently reads as bullish based on above its 50- & 200-day averages, 79% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.
What’s behind the score
Price trendAbove its 50- & 200-day averages
52-week range79% of the way from its 52-week low to high
Market cap
—
52-wk high
$217.98
52-wk low
$143.66
50-day avg
$170.73
200-day avg
$180.79
Trailing P/E
—